ISTA Pharmaceuticals
ISTA Pharmaceuticals, Inc, was a US-based pharmaceutical company that specialized in ophthalmic pharmaceutical products and discovers, develops, and markets therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. ISTA was acquired by Bausch & Lomb, an eye care company, on March 26, 2012. Under the deal, Bausch & Lomb have agreed to pay $9.10 per share for ISTA, bringing the total value of the acquisition to $500 million. In 2012, Valeant Pharmaceuticals withdrew its $360 million offer.
Wikipage disambiguates
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
ISTA Pharmaceuticals
ISTA Pharmaceuticals, Inc, was a US-based pharmaceutical company that specialized in ophthalmic pharmaceutical products and discovers, develops, and markets therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. ISTA was acquired by Bausch & Lomb, an eye care company, on March 26, 2012. Under the deal, Bausch & Lomb have agreed to pay $9.10 per share for ISTA, bringing the total value of the acquisition to $500 million. In 2012, Valeant Pharmaceuticals withdrew its $360 million offer.
has abstract
ISTA Pharmaceuticals, Inc, was ...... thdrew its $360 million offer.
@en
founding year
industry
location
type
Link from a Wikipage to an external page
Wikipage page ID
24,870,486
page length (characters) of wiki page
Wikipage revision ID
1,019,616,678
Link from a Wikipage to another Wikipage
foundation
homepage
industry
key people
Glenn E. Davis
@en
Kathleen McGinley
@en
Marvin J. Garrett
@en
Vicente Anido Jr., Ph.D.
@en
Location
logo
@en
name
ISTA Pharmaceuticals, Inc.
@en
type
wikiPageUsesTemplate
subject
hypernym
comment
ISTA Pharmaceuticals, Inc, was ...... thdrew its $360 million offer.
@en
label
ISTA Pharmaceuticals
@en
wasDerivedFrom
homepage
isPrimaryTopicOf
name
ISTA Pharmaceuticals, Inc.
@en